Latest filings (excl ownership)
10-K
2022 FY
Annual report
31 Mar 23
15-12G
Securities registration termination
30 Jan 23
8-K
Completion of Acquisition or Disposition of Assets
25 Jan 23
EFFECT
Notice of effectiveness
24 Jan 23
EFFECT
Notice of effectiveness
24 Jan 23
POS AM
Prospectus update (post-effective amendment)
19 Jan 23
S-8 POS
Registration of securities for employees (post-effective amendment)
19 Jan 23
POS AM
Prospectus update (post-effective amendment)
19 Jan 23
25-NSE
Exchange delisting
19 Jan 23
8-K
Submission of Matters to a Vote of Security Holders
13 Jan 23
425
Business combination disclosure
4 Jan 23
8-K
Other Events
4 Jan 23
DEFM14A
Proxy related to merger
12 Dec 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
23 Nov 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
17 Nov 22
425
Business combination disclosure
4 Nov 22
10-Q
2022 Q3
Quarterly report
3 Nov 22
425
Business combination disclosure
19 Oct 22
8-K
Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement
19 Oct 22
8-K
Other Events
12 Sep 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
RW
Registration withdrawal request
25 Jul 22
S-1/A
IPO registration (amended)
18 Jul 22
S-1
IPO registration
8 Jul 22
8-K
Other Events
5 Jul 22
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 22
8-K
Termination of a Material Definitive Agreement
3 Jun 22
10-Q
2022 Q1
Quarterly report
16 May 22
DEFA14A
Additional proxy soliciting materials
27 Apr 22
DEF 14A
Definitive proxy
27 Apr 22
10-K
2021 FY
Annual report
28 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
8-K
Other Events
16 Sep 21
10-Q
2021 Q2
Quarterly report
12 Aug 21
8-K
Departure of Directors or Certain Officers
30 Jul 21
EFFECT
Notice of effectiveness
16 Jun 21
EFFECT
Notice of effectiveness
16 Jun 21
CORRESP
Correspondence with SEC
11 Jun 21
CORRESP
Correspondence with SEC
11 Jun 21
8-K
Submission of Matters to a Vote of Security Holders
10 Jun 21
Latest ownership filings
3
Bridget A Martell
1 Nov 23
3
Pini Orbach
1 Nov 23
3
Roy Golan
31 Oct 23
SC 13G/A
Redmile Group, LLC
8 Feb 23
SC 13G
Harel Insurance Investments & Financial Services Ltd.
7 Feb 23
SC 13G/A
WELLINGTON MANAGEMENT GROUP LLP
6 Feb 23
4
Yair Chaim Schindel
24 Jan 23
4
DAVID SIDRANSKY
23 Jan 23
4
Yossi Maimon
23 Jan 23
4
Robert J. Spiegel
23 Jan 23
4
Gary B. Gordon
23 Jan 23
4
MURRAY A GOLDBERG
23 Jan 23
4
Vered Bisker-Leib
23 Jan 23
4
Roni Mamluk
23 Jan 23
SC 13G/A
Schindel Yair Chaim
23 Jan 23
SC 13G/A
Schindel Yair Chaim
9 Jan 23
SC 13G/A
Novartis Institutes for BioMedical Research, Inc.
31 Oct 22
4
MURRAY A GOLDBERG
15 Jun 22
4
DAVID SIDRANSKY
15 Jun 22
4
Robert J. Spiegel
15 Jun 22
4
Vered Bisker-Leib
15 Jun 22
4
Yossi Maimon
16 May 22
4
Roni Mamluk
16 May 22
4
Gary B. Gordon
16 May 22
SC 13G/A
Redmile Group, LLC
14 Feb 22
SC 13G/A
WELLINGTON MANAGEMENT GROUP LLP
4 Feb 22
SC 13G/A
Harel Insurance Investments & Financial Services Ltd.
31 Jan 22
SC 13G/A
Schindel Yair Chaim
24 Jan 22
4
Roni Mamluk
5 Jan 22
4
Gary B. Gordon
5 Jan 22
4
Yossi Maimon
5 Jan 22
4
Vered Bisker-Leib
14 Jun 21
4
Robert J. Spiegel
14 Jun 21
4
DAVID SIDRANSKY
14 Jun 21
4
MURRAY A GOLDBERG
14 Jun 21
4
Todd Sone
14 Jun 21
4
DAVID SIDRANSKY
8 Mar 21
SC 13G/A
Redmile Group, LLC
2 Mar 21
4
Gary B. Gordon
26 Feb 21
4
Roni Mamluk
24 Feb 21